Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib

Published:2018-05-24 Issue:15 Volume:124 Page:3192-3200
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Gordon Max J.¹^ORCID,Churnetski Michael²,Alqahtani Hamood³,Rivera Xavier⁴^ORCID,Kittai Adam¹,Amrock Stephen M.¹,James Spencer⁵,Hoff Sheila³,Manda Sudhir⁵,Spurgeon Stephen E.¹,Choi Michael³,Cohen Jonathon B.²,Persky Daniel⁴,Danilov Alexey V.¹⁵

Affiliation:

1. Oregon Health and Science UniversityPortland Oregon

2. Winship Cancer InstituteEmory UniversityAtlanta Georgia

3. Moores Cancer CenterUniversity of California San DiegoSan Diego California

4. University of ArizonaTucson Arizona

5. Dartmouth‐Hitchcock Medical CenterLebanon New Hampshire

Funder

Lymphoma Research Foundation's Clinical Investigator Career Development Award

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.31554

Reference30 articles.

1. Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia

2. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century

3. Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia

4. In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI

5. Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the interplay between chronic lymphocytic leukemia and type 2 diabetes;Expert Review of Hematology;2024-07-26

2. Comparison of Comorbidity Models Within a Population-Based Cohort of Older Adults With Non-Hodgkin Lymphoma;JCO Clinical Cancer Informatics;2024-04

3. Optimization of mHealth behavioral interventions for patients with chronic lymphocytic leukemia: the HEALTH4CLL study;J CANCER SURVIV;2024

4. Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis;Annals of Hematology;2024-02-10

5. Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real‐life multicenter Italian cohort;Hematological Oncology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3